UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000015953
Receipt number R000018556
Scientific Title A study on the effect of transcranial direct current stimulation on cognitive impairment in schizophrenia
Date of disclosure of the study information 2015/12/15
Last modified on 2016/06/15 17:07:40

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the effect of transcranial direct current stimulation on cognitive impairment in schizophrenia

Acronym

The effect of transcranial direct current stimulation in schizophrenia

Scientific Title

A study on the effect of transcranial direct current stimulation on cognitive impairment in schizophrenia

Scientific Title:Acronym

The effect of transcranial direct current stimulation in schizophrenia

Region

Japan


Condition

Condition

schizophrenia

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the effect of tDCS on cognitive function and depressive symptoms in patients with schizophrenia

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Brief Assessment of Cognitive function in Schizophrenia Japanese version

Key secondary outcomes

CDSS(Calgary Depression Scale for Schizophrenics)
PANSS(Positive and Negative Syndrome Scale)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

transcranial direct current stimulation
(twice daily for 5 days)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Meeting DSM-5 criteria for shiczophrenia

(2)Able to understand the purposes and nature of the study and provide consetnt to agree to participate in it

Key exclusion criteria

(1)Having severe organic brain regions, head trauma with consciousness loss lasting more than 10 minutues, and/or present or past history of epilepsy

(2) Having alcohol or other substances abuse (excluding caffeine and nicotine) witnin 12 months of the baseline assessment

(3)Contra-indicated to ECT or tDCS (e.g. history of brain injury)

(4) Unqualified to the study based on the investigator's judgment

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Tomiki Sumiyoshi

Organization

National Center of Neurology and Psychiatry

Division name

Translational Medical Center

Zip code


Address

4-1-1- Ogawahigashi, Kodaira, Tokyo 187-8551 Japan

TEL

+81-42-341-2711

Email

sumiyot@ncnp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kazuko Iwase

Organization

National Center of Neurology and Psychiatry

Division name

Translational Medical Center

Zip code


Address

4-1-1- Ogawahigashi, Kodaira, Tokyo 187-8551 Japan

TEL

+81-42-341-2711

Homepage URL


Email

iwase@ncnp.go.jp


Sponsor or person

Institute

National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Japanese Society of the Promotion of Sciences

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

YES

Study ID_1

A2014-100

Org. issuing International ID_1

National Center of Neurology and Psychiatry

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立精神・神経医療研究センター病院(東京都)


Other administrative information

Date of disclosure of the study information

2015 Year 12 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2014 Year 11 Month 28 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 05 Day

Last follow-up date

2017 Year 12 Month 31 Day

Date of closure to data entry

2018 Year 03 Month 01 Day

Date trial data considered complete

2018 Year 03 Month 15 Day

Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 12 Month 15 Day

Last modified on

2016 Year 06 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018556


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name